<DOC>
	<DOCNO>NCT02271971</DOCNO>
	<brief_summary>The purpose study determine whether supplementation oral vitamin D ( cholecalciferol ) improve metabolic parameter patient moderate severe psoriasis .</brief_summary>
	<brief_title>Effect Vitamin D Supplementation Metabolic Parameters Patients With Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Clinical diagnosis moderate severe psoriasis . Being treated methotrexate stable dos al least 1 month . Phototherapy within past 2 month . History psoriatic arthritis , rheumatoid arthritis , type 1 diabetes mellitus inflammatory bowel disease . Use vitamin supplement fish oil supplement past 2 month . Use hypolipidemic drug , hypoglycemic drug , glucose sensitizer , oral corticosteroid , orlistat , cholestyramine , phenobarbital phenytoin within past 2 month . Pregnancy lactation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Psoriasis</keyword>
	<keyword>Vitamin D</keyword>
	<keyword>Metabolic syndrome</keyword>
	<keyword>Insulin resistance</keyword>
	<keyword>Cholesterol</keyword>
	<keyword>Methotrexate</keyword>
	<keyword>Dyslipidemia</keyword>
	<keyword>PASI</keyword>
	<keyword>Psoriasis Area Severity Index</keyword>
</DOC>